Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04725773 · ClinicalTrials.gov registry record
Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04725773: Clinical Trial study, sponsored by University of Florida.
NCT04725773 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04725773 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus internus can improve motor symptoms Parkinson's disease (PD). However, it is not known whether DBS can help reduce the signs and symptoms of the limb-kinetic, ideomotor or ideational apraxia associated with PD or if apraxia can exist as a stimulation induced side effect from DBS therapy. In this study, we look to conduct a pilot study to examine the feasibility of characterizing the prevalence of apraxia in PD patients with chronic, stable DBS.
Primary Outcome
Evaluate the effect of DBS on ideomotor apraxia in PD patients. We will assess the TULIA screening assessment: General instruction: "Seven gestures are demonstrated in a mirror fashion, imitate them as precisely as possible" 1. Bring thumb extended on forehead, other fingers point upwards 2. Wipe dust from shoulder Additional instruction: "For the next five gestures, imagine holding a tool or an object in hand, don't use your fingers as a tool" 3. Drink from a glass 4. Smoke a cigarette 5.
Interventions
- DEVICE Deep brain stimulation effect on apraxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-01-28 |
Why NCT04725773 stopped before completion
NCT04725773 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Deep brain stimulation effect on apraxia is the first listed.
NCT04725773 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04725773 about?
NCT04725773 is a clinical study titled "Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation". Deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus internus can improve motor symptoms Parkinson's disease (PD). However, it is not known whether DBS can help reduce the signs and symptoms of the limb-kinetic, ideomotor or ideational apraxia associated with PD or if apraxia c...
What is the current status of trial NCT04725773?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2021-06-01. Estimated completion is 2024-01-28.
What interventions are being tested in trial NCT04725773?
The interventions under investigation include: Deep brain stimulation effect on apraxia (DEVICE).
Who is sponsoring clinical trial NCT04725773?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI